Company Info
Phone(510) 742-3400
Year Established
2002
Ticker
RVNC
Exchange
NASDAQ
Contacts
Mark J. FoleyCEO
Tobin Schilke
CFO
Dustin Sjuts
President
Dwight Moxie
General Counsel
David A. Hollander, M.D., M.B.A.
CMO
Erica Jordan
CCO, Aesthetics
Company Description
Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product, DaxibotulinumtoxinA for Injection.